Article Versions Notes

Hong C-T, Chan L, Chen K-Y, Lee H-H, Huang L-K, Yang Y-CSH, Liu Y-R, Hu C-J. Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies. Cells. 2022; 11(21):3468. https://doi.org/10.3390/cells11213468

Hong, Chien-Tai, Lung Chan, Kai-Yun Chen, Hsun-Hua Lee, Li-Kai Huang, Yu-Chen S. H. Yang, Yun-Ru Liu, and Chaur-Jong Hu. 2022. "Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies" Cells 11, no. 21: 3468. https://doi.org/10.3390/cells11213468

Hong, C.-T., Chan, L., Chen, K.-Y., Lee, H.-H., Huang, L.-K., Yang, Y.-C. S. H., Liu, Y.-R., & Hu, C.-J. (2022). Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies. Cells, 11(21), 3468. https://doi.org/10.3390/cells11213468